Tenon Medical Waives Investor Limits to Expand At-the-Market Share Sales
Tenon Medical, Nasdaq-listed medical device company, obtained a waiver from an institutional investor that lets it increase the number of shares it can sell under its at-the-market offering, in exchange for a new warrant to buy 125,000 shares at $5.02 per share. The company also agreed to register resale of the warrant shares, which may add shares available for sale into the market.
Key points
- On October 16, 2026, the investor waived restrictions in its August 27, 2026 purchase agreement to allow a larger at-the-market offering under the August 11, 2026 sales agreement with A.G.P./Alliance Global Partners.
- The investor received a Series B warrant for up to 125,000 shares at $5.02 per share, expiring September 14, 2031.
- The restriction period under Section 4.12(a) was extended by 15 days, to 75 days after the Effective Date.
- The company must file a resale registration statement on Form S-3 within 60 calendar days of the waiver.
The filing
Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 22, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.